Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dextra Laboratories is a specialist biotechnology company focused on the synthesis and supply of complex carbohydrates and glycoconjugates for the life sciences industry. Based in Reading, UK, the company offers an extensive catalog of over 1,000 carbohydrate-based products, including human milk oligosaccharides (HMOs), blood group antigens, and glycan research tools. In addition to its product portfolio, Dextra provides custom synthesis and contract research services to support drug discovery and development in glycobiology. The company is a key partner for pharmaceutical and diagnostic firms seeking expertise in carbohydrate chemistry, process development, and scale-up. Dextra operates as a subsidiary of the ICE Group, leveraging global manufacturing capabilities to serve the biotech and pharma sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dextra Group.